NCT05990153

Brief Summary

The study aims to evaluate which is the best approach for the non-pharmacological treatment of patients with different types of primary headaches (tension-type headache (TTC), trigeminal autonomic headache (TACs) and migraine) or cervicogenic headache by comparing three methods of intervention to control treatment (drug therapy): therapeutic exercise (TE), myofascial release + TE, and Mulligan's manual therapy + TE. The efficacy will be evaluated in terms of reduction of headache episodes, pain intensity and its duration.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 5, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 29, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

August 14, 2023

Status Verified

August 1, 2023

Enrollment Period

1.8 years

First QC Date

May 29, 2023

Last Update Submit

August 10, 2023

Conditions

Keywords

headacherehabilitationmanual therapyexercise

Outcome Measures

Primary Outcomes (3)

  • Headache frequency

    number of headache attacks in one month

    4 weeks (end of treatment)

  • Headache frequency

    number of headache attacks in one month

    3 months after the end of the treatment

  • Headache frequency

    number of headache attacks in one month

    6 months after the end of the treatment

Secondary Outcomes (24)

  • Headache clinical presentation

    4 weeks (end of treatment)

  • Headache clinical presentation

    3 months after the end of the treatment

  • Headache clinical presentation

    6 months after the end of the treatment

  • Headache related disability

    4 weeks (end of treatment)

  • Headache related Disability

    3 months after the end of the treatment

  • +19 more secondary outcomes

Study Arms (4)

Myofascial Release (MR) + Therapeutic exercise (TE)

EXPERIMENTAL

Patients in the MR+TE group will undergo 12 sessions (3 d/week) of sub-occipital inhibition treatment as a combined muscle and soft tissue inhibition technique. The physiotherapist will apply deep pressure which will be maintained for a total of 10 minutes until the sub-occipital tissues are released. In addition to this technique, the method of pumping and manual treatment (acupressure) of the trigger points on the sub-occipital muscles, on the upper bundles of the trapezius bilaterally, on the sternocleidomastoid bilaterally and on the scalene muscles bilaterally will be applied for a further 10 minutes for a total treatment with myofascial release equal to 20 minutes. At the end of the MR session, the 20-minute TE session will be performed in the same way as described in the TE intervention group.

Other: Myofascial Release (MR)Other: Therapeutic exercise (TE)

Manual therapy (MT) + Therapeutic exercise (TE)

EXPERIMENTAL

The MT+TE intervention group will carry out rehabilitation treatment with a structured protocol based on mobilizations according to the Mulligan method. Treatment according to Mulligan will be carried out at the discretion of the therapist on the basis of daily evaluations of cervical dysfunction and the eventual manifestation of headache. 5 different techniques will be performed on the patient in 12 sessions (3 v/week, for 4 weeks) as described in Satpute, K., Bedekar, N. \& Hall, T. Effectiveness of Mulligan manual therapy over exercise on headache frequency, intensity and disability for patients with migraine, tension-type headache and cervicogenic headache - a protocol of a pragmatic randomized controlled trial. BMC Musculoskelet Disord 22, (2021)..

Other: Manual therapy (MT)Other: Therapeutic exercise (TE)

Therapeutic exercise (TE)

EXPERIMENTAL

Patients in the TE intervention group will be asked to perform 12 sessions (3 day/week) of TE supervised by a physiotherapist. Each session will have a total duration of 40 min divided into 20 min of aerobic exercise and 20 min of TE. Aerobic exercise consists of a total of 20 min of activity on a stationary bike using parameters to increase performance (intensity over 20 min) progressively based on fatigue (Borg scale).The TE consists of warm-up and cool-down exercises for the cervical ROM, associated with stretching exercises of the cervical and scapulothoracic muscles. After the warm-up, muscle strengthening exercises will be performed (isometric, concentric and eccentric contractions of the cervical muscles).

Other: Therapeutic exercise (TE)

Control

ACTIVE COMPARATOR

Patients assigned to the control group will follow the pharmacological treatment according to medical doctor indications (clinical practice).

Drug: clinical practice drug treatment

Interventions

Myofascial release therapy is a type of gentle, constant massage that releases tightness and pain throughout myofascial tissues.

Myofascial Release (MR) + Therapeutic exercise (TE)

drug treatment according to the medical indications of clinical practice

Control

The manual therapy consists of the concurrent application of sustained accessory mobilization applied by a therapist and an active physiological movement to end range applied by the patient. Passive end-of-range overpressure, or stretching, is then delivered without pain as a barrier.

Also known as: Mulligan Concept
Manual therapy (MT) + Therapeutic exercise (TE)

The ET consists of an initial phase of aerobic exercise (cyclette), subsequently the intervention foresees exercises for the cervical ROM, stretching exercises of the cervical and scapulothoracic muscles and muscle strengthening exercises (isometric, concentric and eccentrics of the cervical musculature).

Manual therapy (MT) + Therapeutic exercise (TE)Myofascial Release (MR) + Therapeutic exercise (TE)Therapeutic exercise (TE)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients suffering from primary headache or cervicogenic headache;
  • Age \> 18 years;
  • signature of the informed consent.

You may not qualify if:

  • upper cervical spine instability;
  • cervical arterial insufficiency
  • cervical spine fractures
  • pregnancies
  • rheumatoid arthritis
  • severe cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Department Fondazione Policlinico Universitario Campus Bio-Medico

Roma, RM, 00128, Italy

RECRUITING

MeSH Terms

Conditions

HeadacheMotor Activity

Interventions

Myofascial Release TherapyMusculoskeletal ManipulationsExercise Therapy

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitationAftercareContinuity of Patient CarePatient Care

Study Officials

  • Silvia Sterzi, MD

    Fondazione Policlinico Universitario Campus Bio-Medico

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
the assessor is unaware of the type of treatment the patients have received
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The allocation sequence will occur by 1:1:1:1 randomization, using the Clinical Trial Randomization tool (web https://ctrandomization.cancer.gov/), stratifying by headache type. The allocation of patients will be hidden, through the use of sealed envelopes in which the randomization will be contained. The enrollment will be carried out by the medical doctors of the Headache and Neurosonology Center clinics of the Campus Bio-Medico University Hospital Foundation, who will communicate the patient's name to a third person external to the study who will assign the patient according to the randomization plan developed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Physical Medicine and Rehabilitative Unit

Study Record Dates

First Submitted

May 29, 2023

First Posted

August 14, 2023

Study Start

April 5, 2023

Primary Completion

February 1, 2025

Study Completion

April 1, 2026

Last Updated

August 14, 2023

Record last verified: 2023-08

Locations